Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition and development of novel therapeutics for the treatment of cancer.
NASDAQ: PBYI5.17+0.07 ( 1.37% )Vol: 248,185Pricing delayed by 20 minutes. Last Updated 04/17/2024 4:00 PM. Site Search. Puma Biotechnology, Inc. Investors ...
People also ask
Who is the parent company of Puma biotechnology?
What are the results of Puma biotechnology?
Who is the CEO of Puma biotechnology?
How do I contact Puma biotechnology?
$5.51
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Mar 2, 2024 · I would now like to turn the conference call over to Mariann Ohanesian, Senior Director of Investor Relations for Puma Biotechnology. You ...
Discover real-time Puma Biotechnology Inc Common Stock (PBYI) stock prices, quotes, historical data, news, and Insights for informed trading and investment ...
Find the latest Puma Biotechnology, Inc. (PBYI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
May 4, 2023 · (PBYI) Q1 2023 Earnings Call Transcript ... Mariann Ohanesian - Senior Director, Investor Relations ... About PBYI Stock. Symbol, Last Price, % Chg ...
Nov 2, 2023 · Thank you, Camilla. Good afternoon, and welcome to Puma's conference call to discuss our financial results for the third quarter of 2023.
In depth view into PBYI (Puma Biotechnology) stock including the latest price ... Investor Relations URL, https://investor.pumabiotechnology.com/investors-home.
3 hours ago · Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, ...
